Latest Gene therapy Stories
BERGISCH GLADBACH, Germany, August 14, 2014 /PRNewswire/ -- Addition of lentiviral gene delivery capabilities complements strategic partnering portfolio.
SAN DIEGO, Aug. 13, 2014 /PRNewswire/ -- Cardium Therapeutics, an operating unit of Taxus Cardium Pharmaceuticals Group Inc.
Darst and Landes – both of whom lost mothers to cancer – will connect with a younger demographic. Stamford, CT (PRWEB) August 11, 2014 Alliance for
Oncothyreon to Leverage Alpine's Protocell Technology to Enable Targeted Delivery of Molecular Therapeutics for Serious Diseases Company to Hold Conference Call at 4:30
LONDON, July 21, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
New results ease previous concerns that gene-editing techniques—used to develop therapies for genetic diseases—could add unwanted mutations to stem cells.
Engineered Cells Known As CTL019 Are the First Therapy of Their Kind to Obtain Designation PHILADELPHIA, July 7, 2014 /PRNewswire/ -- A University of Pennsylvania-developed personalized
Eighth annual Greenwich-Stamford Open Water Swim unites Connecticut residents to find a cure. Stamford, CT (PRWEB) June 25, 2014 Over 300 volunteers
Pioneering Angiogenic Gene Therapy for the Potential Treatment of Millions of Patients with Heart Disease Worldwide SAN DIEGO, June 24, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals
LEVERKUSEN, Germany, June 23, 2014 /PRNewswire/ -- Bayer HealthCare (Bayer) and Dimension Therapeutics, a company focused on developing novel adeno-associated virus (AAV) gene therapy
- The act of sweetening by admixture of some saccharine substance.
More Images (1 images) »